Effect of weekly or daily dosing regimen of Gefitinib in mouse models of lung cancer

Oncotarget
Qi ZhangMing You

Abstract

Gefitinib showed response in phase II clinical trials and with better clinical response in lung cancer with activating mutations in the tyrosine kinase domain of the EGFR. Questions of toxicity and potential dosing regimens impede the use in a prevention setting. This study will provide scientific evidence for the utility of testing and comparing weekly and daily dosing regimens in clinical trials. We employed the adenocarcinoma (AD) and squamous cell carcinoma (SCC) models to compare the efficacy of Gefitinib in daily or weekly dosing regimens. We also assessed the effectiveness of Gefitinib in altering growth of the H3255 xenograft. Bioluminescent imaging (BLI) and tumor size was evaluated. Relative expression of phospho-EGFR, phospho-ERK and phospho-AKT in the xenograft were evaluated by Western Blot analysis. In the lung AD model, Gefitinib showed significant inhibition of tumor load when treated with weekly or weekly intermittent dosing regimens in AJ/p53 (val135/wt) mice whereas a daily dosing regimen did not decrease the tumor load significantly. In the H3255-Luciferase xenograft model, weekly treatment demonstrated better inhibition than daily treatment. The weekly dosing regimen exhibited greater inhibition of phospho-...Continue Reading

References

Jul 1, 1995·Critical Reviews in Oncology/hematology·D S SalomonN Normanno
Feb 24, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Martin H CohenRichard Pazdur
Apr 28, 2004·Annals of Oncology : Official Journal of the European Society for Medical Oncology·A HaringhuizenN van Zandwijk
Jul 31, 2004·Science·Raffaella SordellaJeffrey Settleman
Dec 22, 2004·Current Treatment Options in Oncology·Ariel Birnbaum, Neal Ready
Apr 9, 2005·The Journal of Immunology : Official Journal of the American Association of Immunologists·Saveria PastoreGiampiero Girolomoni
Aug 27, 2005·Expert Opinion on Biological Therapy·Apar Kishor Ganti, Anil Potti
Aug 10, 2006·Cancer Chemotherapy and Pharmacology·Matthew G FuryNaiyer A Rizvi
Dec 26, 2006·Molecular Cancer Research : MCR·Ying YanMing You
Jul 14, 2010·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Emma Guttman-YasskyJames G Krueger
Feb 1, 2011·Nature Reviews. Clinical Oncology·Christine M Lovly, David P Carbone
Jul 23, 2011·Annals of Oncology : Official Journal of the European Society for Medical Oncology·H K ChewA M Davies
Jan 14, 2012·Expert Opinion on Therapeutic Targets·Parthasarathy SeshacharyuluSurinder K Batra
Dec 25, 2012·Genes & Cancer·Ahmed El-Telbany, Patrick C Ma
Mar 28, 2013·Cancer Prevention Research·Ronald A LubetClinton J Grubbs
Sep 5, 2013·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Steven M Dubinett, Avrum Spira
Jan 31, 2015·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Oscar ArrietaMauricio Cuello
Dec 17, 2015·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Ji Yun LeeMyung-Ju Ahn
Jan 9, 2016·CA: a Cancer Journal for Clinicians·Rebecca L SiegelAhmedin Jemal

❮ Previous
Next ❯

Citations

Feb 3, 2018·Expert Opinion on Drug Discovery·Aditi P SinghHaiying Cheng
Apr 26, 2019·Toxicological Sciences : an Official Journal of the Society of Toxicology·Altaf MohammedMark Steven Miller
Jul 5, 2021·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Renyikun YuanShilin Yang

❮ Previous
Next ❯

Methods Mentioned

BETA
xenograft
chip

Software Mentioned

NanoZoomer Digital Pathology Virtual Slide Viewer

Related Concepts

Related Feeds

Alzheimer's Disease: Neuroimaging

Neuroimaging can help identify pathological hallmarks of Alzheimer's disease (AD). Here is the latest research on neuroimaging modalities, including magnetic resonance imaging and positron emission tomography, in AD.

Alzheimer's Disease: Animal Models

Alzheimer's disease is a neurodegenerative disease which can be studied using various experimental systems. This feed focuses on animal models used for Alzheimer's disease research.

Carcinoma, Squamous Cell

Basal cell carcinoma is a form of malignant skin cancer found on the head and neck regions and has low rates of metastasis. Discover the latest research on basal cell carcinoma here.

Related Papers

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
Humberto Lara-GuerraNatasha B Leighl
Lung Cancer : Journal of the International Association for the Study of Lung Cancer
Kenji SugioKosei Yasumoto
Zhonghua zhong liu za zhi [Chinese journal of oncology]
Li Zhang, Shi-Ying Yu
© 2022 Meta ULC. All rights reserved